Sustained delivery of bioactive TGF-β1 from self-assembling peptide hydrogels induces chondrogenesis of encapsulated bone marrow stromal cells

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 5, 2014, Pages 1275-1285

  Kopesky, Paul W ^a   Byun, Sangwon ^b   Vanderploeg, Eric J ^a   Kisiday, John D ^c   Frisbie, David D ^c   Grodzinsky, Alan J ^a,b  

^a Massachusetts Institute of Technology   (United States)

^b Department of Electrical Engineering and Computer Science   (United States)

^c Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

bone marrow stromal cell; cartilage repair; regenerative medicine; sustained delivery; tissue engineering

Indexed keywords

BONE; CARTILAGE; CELLS; CYTOLOGY; PEPTIDES; REPAIR; SCAFFOLDS (BIOLOGY); TISSUE ENGINEERING;

ANTI-INFLAMMATORIES; BONE MARROW STROMAL CELLS; BONE MARROW STROMAL CELLS (BMSCS); CARTILAGE REPAIR; REGENERATIVE MEDICINE; SELF-ASSEMBLING PEPTIDES; SUSTAINED DELIVERY; TRANSFORMING GROWTH FACTORS;

HYDROGELS;

AGAROSE; IODINE 125; SEPHADEX; TRANSFORMING GROWTH FACTOR BETA1; DELAYED RELEASE FORMULATION; HYDROGEL; PEPTIDE; RADIOACTIVE IODINE; SEPHAROSE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW STROMAL CELL; CARTILAGE; CATTLE; CELL ENCAPSULATION; CHONDROGENESIS; CONTROLLED STUDY; DNA CONTENT; DRUG DELIVERY SYSTEM; EQUIDAE; HYDROGEL; NONHUMAN; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGENERATIVE MEDICINE; STROMA CELL; TISSUE ENGINEERING; ADSORPTION; ANIMAL; BOVINAE; CYTOLOGY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; HORSE; HUMAN; IMMOBILIZED CELL; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY;

ADSORPTION; ANIMALS; CATTLE; CELLS, IMMOBILIZED; CHONDROGENESIS; DELAYED-ACTION PREPARATIONS; HORSES; HUMANS; HYDROGELS; IODINE RADIOISOTOPES; MESENCHYMAL STROMAL CELLS; PEPTIDES; SEPHAROSE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84897108962     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34789     Document Type: Article

References (48)

1. Noth U, Steinert AF, Tuan RS,. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 2008; 4: 371-380. (Pubitemid 351974009)
2. Steinert AF, Ghivizzani SC, Rethwilm A, Tuan RS, Evans CH, Noth U,. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther 2007; 9: 213.
3. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B,. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: A patient-matched comparison. J Orthop Res 2005; 23: 1383-1389. (Pubitemid 41554672)
4. Barry F, Boynton RE, Liu B, Murphy JM,. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components. Exp Cell Res 2001; 268: 189-200. (Pubitemid 32744650)
5. Kisiday JD, Kopesky PW, Evans CH, Grodzinsky AJ, McIlwraith CW, Frisbie DD,. Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 2008; 26: 322-331.
6. Mauck RL, Nicoll SB, Seyhan SL, Ateshian GA, Hung CT,. Synergistic action of growth factors and dynamic loading for articular cartilage tissue engineering. Tissue Eng 2003; 9: 597-611. (Pubitemid 37048103)
7. Park JS, Yang HN, Woo DG, Chung HM, Park KH,. In vitro and in vivo chondrogenesis of rabbit bone marrow-derived stromal cells in fibrin matrix mixed with growth factor loaded in nanoparticles. Tissue Eng Part A 2009; 15: 2163-2175.
8. Jung Y, Chung YI, Kim SH, Tae G, Kim YH, Rhie JW, Kim SH, Kim SH,. In situ chondrogenic differentiation of human adipose tissue-derived stem cells in a TGF-beta1 loaded fibrin-poly(lactide-caprolactone) nanoparticulate complex. Biomaterials 2009; 30: 4657-4664.
9. Holland TA, Tabata Y, Mikos AG,. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release 2003; 91: 299-313. (Pubitemid 36976762)
10. Yamamoto M, Ikada Y, Tabata Y,. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 2001; 12: 77-88. (Pubitemid 32331415)
11. Ahearne M, Buckley CT, Kelly DJ,. A growth factor delivery system for chondrogenic induction of infrapatellar fat pad-derived stem cells in fibrin hydrogels. Biotechnol Appl Biochem 2011; 58: 345-352.
12. Diederichs S, Baral K, Tanner M, Richter W,. Interplay between local versus soluble transforming growth factor-beta and fibrin scaffolds: role of cells and impact on human mesenchymal stem cell chondrogenesis. Tissue Eng Part A 2012; 18: 1140-1150.
13. Maire M, Logeart-Avramoglou D, Degat MC, Chaubet F,. Retention of transforming growth factor beta1 using functionalized dextran-based hydrogels. Biomaterials 2005; 26: 1771-1780. (Pubitemid 39575320)
14. Rajangam K, Arnold MS, Rocco MA, Stupp SI,. Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity. Biomaterials 2008; 29: 3298-3305.
15. Branco MC, Pochan DJ, Wagner NJ, Schneider JP,. Macromolecular diffusion and release from self-assembled beta-hairpin peptide hydrogels. Biomaterials 2009; 30: 1339-1347.
16. Zhang S, Holmes T, Lockshin C, Rich A,. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci USA 1993; 90: 3334-3338. (Pubitemid 23111360)
17. Holmes TC,. Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotechnol 2002; 20: 16-21. (Pubitemid 34015904)
18. Zhang S, Gelain F, Zhao X,. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol 2005; 15: 413-420. (Pubitemid 41140309)
19. Miller RE, Grodzinsky AJ, Vanderploeg EJ, Lee C, Ferris DJ, Barrett MF, Kisiday JD, Frisbie DD,. Effect of self-assembling peptide, chondrogenic factors, and bone marrow-derived stromal cells on osteochondral repair. Osteoarthritis Cartilage 2010; 18: 1608-1619.
20. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT,. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006; 116: 237-248. (Pubitemid 43121809)
21. Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD, Zhang S, Lee RT,. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005; 111: 442-450. (Pubitemid 40204428)
22. Nagai Y, Unsworth LD, Koutsopoulos S, Zhang S,. Slow release of molecules in self-assembling peptide nanofiber scaffold. J Control Release 2006; 115: 18-25. (Pubitemid 44415076)
23. Koutsopoulos S, Unsworth LD, Nagai Y, Zhang S,. Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold. Proc Natl Acad Sci USA 2009; 106: 4623-4628.
24. Davis ME, Hsieh PC, Takahashi T, Song Q, Zhang S, Kamm RD, Grodzinsky AJ, Anversa P, Lee RT,. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci USA 2006; 103: 8155-8160. (Pubitemid 43801068)
25. Serwer P,. Agarose gels: Properties and use for electrophoresis. Electrophoresis 1983; 4: 375-382.
26. Kopesky PW, Vanderploeg EJ, Sandy JD, Kurz B, Grodzinsky AJ,. Self-assembling peptide hydrogels modulate in vitro chondrogenesis of bovine bone marrow stromal cells. Tissue Eng Part A 2010; 16: 465-477.
27. Byun S, Tortorella MD, Malfait AM, Fok K, Frank EH, Grodzinsky AJ,. Transport and equilibrium uptake of a peptide inhibitor of PACE4 into articular cartilage is dominated by electrostatic interactions. Arch Biochem Biophys 2010; 499: 32-39.
28. Connelly JT, Garcia AJ, Levenston ME,. Interactions between integrin ligand density and cytoskeletal integrity regulate BMSC chondrogenesis. J Cell Physiol 2008; 217 (1): 145-154.
29. Kopesky PW, Lee HY, Vanderploeg EJ, Kisiday JD, Frisbie DD, Plaas AH, Ortiz C, Grodzinsky AJ,. Adult equine bone marrow stromal cells produce a cartilage-like ECM mechanically superior to animal-matched adult chondrocytes. Matrix Biol 2010; 29: 427-438.
30. Kim YJ, Sah RL, Doong JY, Grodzinsky AJ,. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 1988; 174: 168-176. (Pubitemid 18261664)
31. Farndale RW, Sayers CA, Barrett AJ,. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982; 9: 247-248. (Pubitemid 12009669)
32. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW,. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 2009; 27: 1675-1680.
33. Frisbie DD, Lu Y, Kawcak CE, DiCarlo EF, Binette F, McIlwraith CW,. In vivo evaluation of autologous cartilage fragment-loaded scaffolds implanted into equine articular defects and compared with autologous chondrocyte implantation. Am J Sports Med 2009; 37: 71S-80S.
34. Kopesky PW, Vanderploeg EJ, Kisiday JD, Frisbie DD, Sandy JD, Grodzinsky AJ,. Controlled delivery of transforming growth factor beta1 by self-assembling peptide hydrogels induces chondrogenesis of bone marrow stromal cells and modulates Smad2/3 signaling. Tissue Eng Part A 2011; 17: 83-92.
35. Vehof JW, Haus MT, de Ruijter AE, Spauwen PH, Jansen JA,. Bone formation in transforming growth factor beta-I-loaded titanium fiber mesh implants. Clin Oral Implants Res 2002; 13: 94-102. (Pubitemid 41719945)
36. Fischer U, Hempel U, Becker D, Bierbaum S, Scharnweber D, Worch H, Wenzel KW,. Transforming growth factor beta1 immobilized adsorptively on Ti6Al4V and collagen type I coated Ti6Al4V maintains its biological activity. Biomaterials 2003; 24: 2631-2641. (Pubitemid 36506485)
37. Narayanan J, Xiong J-Y, Liu X-Y,. Determination of agarose gel pore size: Absorbance measurements vis a vis other techniques. J Phys Conf Ser 2006; 28: 83-86. (Pubitemid 43208003)
38. Sieminski AL, Semino CE, Gong H, Kamm RD,. Primary sequence of ionic self-assembling peptide gels affects endothelial cell adhesion and capillary morphogenesis. J Biomed Mater Res A 2008; 87: 494-504.
39. Schlunegger MP, Grutter MG,. An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2. Nature 1992; 358: 430-434.
40. Segers VF, Lee RT,. Local delivery of proteins and the use of self-assembling peptides. Drug Discov Today 2007; 12: 561-568. (Pubitemid 47031660)
41. Re'em T, Kaminer-Israeli Y, Ruvinov E, Cohen S,. Chondrogenesis of hMSC in affinity-bound TGF-beta scaffolds. Biomaterials 2012; 33: 751-761.
42. Massague J, Kelly B,. Internalization of transforming growth factor-beta and its receptor in BALB/c 3T3 fibroblasts. J Cell Physiol 1986; 128: 216-222. (Pubitemid 16047931)
43. Clarke DC, Brown ML, Erickson RA, Shi Y, Liu X,. Transforming growth factor beta depletion is the primary determinant of Smad signaling kinetics. Mol Cell Biol 2009; 29: 2443-2455.
44. Carpenter G, Cohen S,. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol 1976; 71: 159-171.
45. Tsujimoto M, Yip YK, Vilcek J,. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc Natl Acad Sci USA 1985; 82: 7626-7630. (Pubitemid 16204401)
46. Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumur M, Fujinag T,. Gene expression profile of bovine bone marrow mesenchymal stem cell during spontaneous chondrogenic differentiation in pellet culture system. Jpn J Vet Res 2006; 53: 127-139.
47. Bian L, Zhai DY, Tous E, Rai R, Mauck RL, Burdick JA,. Enhanced MSC chondrogenesis following delivery of TGF-beta3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. Biomaterials 2011; 32: 6425-6434.
48. Li J, Anemaet W, Diaz MA, Buchanan S, Tortorella M, Malfait AM, Mikecz K, Sandy JD, Plaas A,. Knockout of ADAMTS5 does not eliminate cartilage aggrecanase activity but abrogates joint fibrosis and promotes cartilage aggrecan deposition in murine osteoarthritis models. J Orthop Res 2011; 29: 516-522.